Grail is a biotechnology company headquartered in Menlo Park, California that was founded by Jeffrey Huber, Sjuul van den Eertweg in 2016 focused on making a medical device that can detect early stage cancer.
Human genome sequencing company founded in 2013 and based in San Diego, CA. Human Longevity Inc. is building a database with genomic and phenotypic information and aims to make medicine more data-driven by combining DNA sequencing, expert analysis and machine learning
Hesperos is a biotechnology company that develops human-on-a-chip systems that integrate several body organ modules to replicate organ interplay that can be used to analyse drug candidates and compounds for efficacy and toxicity and also study disease.
An Australian clinical stage regenerative medicine company founded in 2007 developing cellular therapies based on stem cells and stem cell secretions to treat osteoarthritis, cancer, skin conditions and chronic pain.
RoosterBio is a biotechnology company located in Frederick, Maryland, founded by Jon Rowley in 2013 providing standardized stem cell products for R&D, clinical, and commercial use in the regenerative medicine industry.
Nebula Genomics is a genetics company developing a platform for individuals to get their personal genome sequenced, and then enable them to store and control that information through cryptographic encryption on the blockchain.
Aegle Therapeutics Corporation, a regenerative medicine company isolating extracellular vesicles ("EVs") from allogeneic bone marrow derived mesenchymal stem cells (MSCs) to treat severe dermatological conditions, including burns and epidermolysis bullosa (“EB”).
Exopharm is a regenerative medicine biopharmaceutical company spun out of Altnia Group. Founded in 2003 and based in Melbourne, Australia, the company aims to develop and commercialize exosomes as therapeutic agents.
A biotechnology company founded in 2013 that develops technology to treat heart disease using pluripotent stem cells. Disease in a dish and clinical trial in a dish platforms are used to develop cardiovascular drugs and perform cardio-toxicity safety testing for non-cardiovascular drugs.
Autolus is a biopharmaceutical company focused on programmed T-cell therapies for treatment of cancer. Autolus was founded in 2014 and is based in London, UK. Autolus Limited is a subsidiary of Autolus Holdings (UK) Limited.
Current Health (formerly snap40) is a British company founded in Edinburgh, Scotland, in 2015 by Christopher McCann and Stewart Whiting. The company produces remote patient monitoring systems that enable hospitals to discharge patients sooner, reduce readmissions, and respond early to signs of deterioration.
A bioinformatics startup company that develops and applies artificial intelligence and machine learning technology to analyze scientific data in order to create human health and bioscience applications.
Company developing software that helps physicians communicate with their patients. Their main product Chain SMS is used by medical office staff to send text messages for a variety of communications such as appointment reminders or to remind patients to take prescriptions.
Acorda is a biotechnology company founded in 1995 by Ron Cohen and headquartered in Ardsley, New York developing and commercializing neurology therapies for Parkinson's disease, migraines, and multiple sclerosis.